EPIC1

Chr 22

epigenetically induced MYC interacting lncRNA 1

Also known as: Lnc-EPIC1

ResearchGenerating clinical summary…
7
Active trials
3
Pubs (1 yr)
P/LP submissions
P/LP missense
LOEUF
Mechanism

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

EPIC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Prostate Cancer

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

ACTIVE NOT RECRUITING
NCT04396808Phase NAUniversity of Michigan Rogel Cancer CenterStarted 2020-11-05
DecipherProlarisOncotype Dx Genomic Prostate Score (GPS)
Prostate Cancer

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

ACTIVE NOT RECRUITING
NCT01368588Phase PHASE3Radiation Therapy Oncology GroupStarted 2011-07
three-dimensional conformal radiotherapyintensity modulated radiotherapyBrachytherapy
Prostate Cancer

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

ACTIVE NOT RECRUITING
NCT04404894Myriad Genetic Laboratories, Inc.Started 2020-04-30
Prostate Adenocarcinoma

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

ACTIVE NOT RECRUITING
NCT05050084Phase PHASE3NRG OncologyStarted 2021-12-06
BicalutamideBuserelinDarolutamide
Prostate CancerRadiotherapy Side Effect

Prostate Reirradiation Toxicity Outcomes Feasibility Study

NOT YET RECRUITING
NCT05614700Phase NAUniversity of LeedsStarted 2022-11-15
BrachytherapySterotactic Body Radiotherapy
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

ACTIVE NOT RECRUITING
NCT04513717Phase PHASE3NRG OncologyStarted 2021-01-21
ApalutamideBicalutamideBiospecimen Collection
Stage II Prostate Adenocarcinoma AJCC v7

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

ACTIVE NOT RECRUITING
NCT03367702Phase PHASE3NRG OncologyStarted 2018-02-01
Intensity-Modulated Radiation TherapyQuality-of-Life AssessmentQuestionnaire Administration